Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference41 articles.
1. PDQ®, National Cancer Institute, Washington, D.C., 2000.
2. Assessing clinical benefit in the treatment of pancreas cancer: Gemcitabine compared to 5-fluorouracil
3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
4. Radiosensitizing Nucleosides
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preclinical safety study of a gemcitabine-controlled release polymer for locoregional administration in pancreatic cancer;Journal of Drug Delivery Science and Technology;2023-09
2. MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy;Molecular Pharmaceutics;2021-04-06
3. Production of drug-releasing biodegradable microporous scaffold impregnated with gemcitabine using a CO2 foaming process;Journal of CO2 Utilization;2020-10
4. Mucins in pancreatic cancer: A well‐established but promising family for diagnosis, prognosis and therapy;Journal of Cellular and Molecular Medicine;2020-08-03
5. Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature;Cancers;2020-02-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3